key: cord-356054-p0b5hkk0
authors: Mousa, Albeir Y.; Nanjundappa, Aravinda
title: My vascular diary on COVID-19 Pandemic and ideal health care settings
date: 2020-07-28
journal: J Vasc Surg Venous Lymphat Disord
DOI: 10.1016/j.jvsv.2020.07.008
sha: 
doc_id: 356054
cord_uid: p0b5hkk0

nan

Presentation includes cough, fever, sputum production, fatigue and shortness of breath. Yet 7 myalgia, headache, pleuritic pain, sore throat, chills, GI symptoms as severe nausea, diarrhea, 8 loss of smell and taste may happen. Pediatric patients are more likely to present with pyrexia, dry 9 cough and wheezing. 1, 2 Being a highly sensitive biomarker for thromboembolic conditions, D 10 dimer has been associated with higher mortality in ICU patients. Initiation of full anticoagulation 11 early on may be beneficial to mitigate the incidence of pulmonary emboli in COVID-19 patients. 12

The current definitive diagnostic test is a real-time reverse PCR test. It is very specific, but only 13 60-70% sensitive, and needs repeated if clinical concern exists. Some physicians will use 14 findings of CT scan or CXR as a surrogate. 15 16 What we should know: (1) Social distancing appears to work. (2) Transmission is via cellular 17 attachment of its "spiky" shaped surface proteins to angiotensin-converting enzyme 2 (ACE 2) 18 receptors in the lung and/or heart with presentations of respiratory and/or cardiovascular 

The Global Impact of COVID-19 on

A military perspective on the vascular surgeon's response to 5 the COVID-19 pandemic

COVID-19-New Insights on a Rapidly Changing Epidemic

Supporting the Health Care Workforce During the COVID-19

Triage 11 Considerations for Patients Referred for Structural Heart Disease Intervention During the 12

COVID-19) Pandemic: An ACC /SCAI Consensus Statement

Priorities for the US Health Community Responding 15 to COVID-19